AstraZeneca Takes Action, Caps Inhaler Price at $35 Amidst Scrutiny Over Drug Costs
AstraZeneca, a leading pharmaceutical company, has announced its decision to cap the cost of its inhalers at $35, a move aimed at…
AstraZeneca, a leading pharmaceutical company, has announced its decision to cap the cost of its inhalers at $35, a move aimed at…